tiprankstipranks
Trending News
More News >
Universe Pharmaceuticals (UPC)
NASDAQ:UPC
US Market

Universe Pharmaceuticals (UPC) Ratios

Compare
212 Followers

Universe Pharmaceuticals Ratios

UPC's free cash flow for Q4 2025 was $0.36. For the 2025 fiscal year, UPC's free cash flow was decreased by $ and operating cash flow was $-0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
4.07 4.07 2.54 2.68 3.17
Quick Ratio
3.90 3.90 2.46 2.43 3.00
Cash Ratio
2.55 2.55 1.45 0.38 0.44
Solvency Ratio
-0.24 -0.24 -0.37 -0.41 -0.63
Operating Cash Flow Ratio
-0.38 -0.38 -0.47 0.08 -0.10
Short-Term Operating Cash Flow Coverage
-0.55 -0.55 -1.62 0.20 -0.33
Net Current Asset Value
$ 40.43M$ 40.43M$ 29.19M$ 23.06M$ 28.41M
Leverage Ratios
Debt-to-Assets Ratio
0.13 0.13 0.12 0.10 0.07
Debt-to-Equity Ratio
0.16 0.16 0.18 0.14 0.08
Debt-to-Capital Ratio
0.14 0.14 0.15 0.12 0.08
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.04 0.00 0.00
Financial Leverage Ratio
1.23 1.23 1.49 1.35 1.28
Debt Service Coverage Ratio
-0.31 -0.31 -1.30 -0.96 -1.74
Interest Coverage Ratio
-12.57 -12.57 -28.83 -22.49 -43.22
Debt to Market Cap
3.63 633.71 8.99 1.62 0.33
Interest Debt Per Share
16.84 2.73K 1.36K 952.09 691.98
Net Debt to EBITDA
8.33 8.33 2.92 -0.06 0.28
Profitability Margins
Gross Profit Margin
35.28%35.28%26.37%31.93%54.53%
EBIT Margin
-19.26%-19.26%-34.06%-11.43%-17.27%
EBITDA Margin
-16.37%-16.37%-31.95%-9.85%-15.94%
Operating Profit Margin
-16.33%-16.33%-34.83%-10.92%-17.49%
Pretax Profit Margin
-20.56%-20.56%-35.27%-12.20%-19.89%
Net Profit Margin
-20.56%-20.56%-37.90%-19.08%-21.76%
Continuous Operations Profit Margin
-20.56%-20.56%-37.90%-19.17%-21.76%
Net Income Per EBT
100.00%100.00%107.47%156.40%109.42%
EBT Per EBIT
125.93%125.93%101.26%111.73%113.74%
Return on Assets (ROA)
-5.30%-5.30%-12.84%-11.57%-14.67%
Return on Equity (ROE)
-6.60%-6.54%-19.18%-15.59%-18.81%
Return on Capital Employed (ROCE)
-5.19%-5.19%-16.83%-8.92%-15.11%
Return on Invested Capital (ROIC)
-4.46%-4.46%-14.99%-7.83%-13.93%
Return on Tangible Assets
-5.32%-5.32%-12.89%-11.60%-14.71%
Earnings Yield
-139.88%-25137.98%-980.96%-182.55%-72.52%
Efficiency Ratios
Receivables Turnover
1.35 1.35 1.29 3.01 2.64
Payables Turnover
6.92 6.92 3.45 4.80 5.93
Inventory Turnover
5.27 5.27 9.76 6.58 8.27
Fixed Asset Turnover
1.21 1.21 1.50 2.16 2.96
Asset Turnover
0.26 0.26 0.34 0.61 0.67
Working Capital Turnover Ratio
0.44 0.50 0.85 1.26 1.19
Cash Conversion Cycle
286.03 286.03 214.98 100.60 120.68
Days of Sales Outstanding
269.50 269.50 283.40 121.21 138.06
Days of Inventory Outstanding
69.26 69.26 37.40 55.48 44.13
Days of Payables Outstanding
52.73 52.73 105.82 76.10 61.50
Operating Cycle
338.76 338.76 320.80 176.70 182.18
Cash Flow Ratios
Operating Cash Flow Per Share
-8.97 -1.45K -1.56K 189.11 -221.57
Free Cash Flow Per Share
-9.44 -1.55K -1.62K 181.65 -237.39
CapEx Per Share
0.47 99.82 59.75 7.46 15.82
Free Cash Flow to Operating Cash Flow
1.05 1.07 1.04 0.96 1.07
Dividend Paid and CapEx Coverage Ratio
-18.94 -14.55 -26.18 25.36 -14.01
Capital Expenditure Coverage Ratio
-18.94 -14.55 -26.18 25.36 -14.01
Operating Cash Flow Coverage Ratio
-0.55 -0.55 -1.19 0.20 -0.33
Operating Cash Flow to Sales Ratio
-0.28 -0.28 -0.41 0.03 -0.03
Free Cash Flow Yield
-202.62%-36963.68%-1109.37%31.87%-11.67%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.69 >-0.01 -0.10 -0.55 -1.38
Price-to-Sales (P/S) Ratio
0.14 <0.01 0.04 0.10 0.30
Price-to-Book (P/B) Ratio
0.05 <0.01 0.02 0.09 0.26
Price-to-Free Cash Flow (P/FCF) Ratio
-0.48 >-0.01 -0.09 3.14 -8.57
Price-to-Operating Cash Flow Ratio
-0.51 >-0.01 -0.09 3.01 -9.18
Price-to-Earnings Growth (PEG) Ratio
<0.01 <0.01 >-0.01 0.02 <0.01
Price-to-Fair Value
0.05 <0.01 0.02 0.09 0.26
Enterprise Value Multiple
7.45 8.32 2.80 -1.12 -1.61
Enterprise Value
-21.71M -24.32M -20.61M 3.57M 10.27M
EV to EBITDA
7.43 8.32 2.80 -1.12 -1.61
EV to Sales
-1.22 -1.36 -0.90 0.11 0.26
EV to Free Cash Flow
4.08 4.50 2.09 3.32 -7.31
EV to Operating Cash Flow
4.30 4.81 2.17 3.19 -7.83
Tangible Book Value Per Share
99.11 16.05K 7.44K 6.65K 7.81K
Shareholders’ Equity Per Share
99.64 16.14K 7.49K 6.67K 7.84K
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 -0.07 -0.57 -0.09
Revenue Per Share
31.70 5.13K 3.79K 5.45K 6.78K
Net Income Per Share
-6.52 -1.06K -1.44K -1.04K -1.48K
Tax Burden
1.00 1.00 1.07 1.56 1.09
Interest Burden
1.07 1.07 1.04 1.07 1.15
Research & Development to Revenue
0.04 0.04 0.13 0.15 0.19
SG&A to Revenue
0.00 0.24 0.14 0.07 0.06
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.38 1.38 1.09 -0.17 0.17
Currency in USD